Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation

被引:51
作者
Nakazawa, H
Lythall, DA
Noh, J
Ishikawa, N
Sugino, K
Ito, K
Hardman, SMC
机构
[1] UCL, Clin & Acad Dept Cardiovasc Med, Sch Med, Whittington Hosp, London N19 5NF, England
[2] Tokai Univ, Dept Physiol, Sch Med, Hiratsuka, Kanagawa 25912, Japan
[3] Kent & Canterbury Hosp, Canterbury, Kent, England
[4] St Thomas Hosp, London, England
[5] Ito Hosp, Tokyo, Japan
关键词
longstanding atrial fibrillation; cardioversion; maintenance of sinus rhythm; disopyramide;
D O I
10.1053/euhj.1999.1956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims As atrial fibrillation is associated with significant mortality and morbidity, restoration of sinus rhythm is desirable. However, previous data suggest that cardioversion should be restricted to patients in whom the fibrillation is of limited duration (<1-2 years) because of high relapse rates. It may be the frequent association with cardiac disease, rather than the duration of fibrillation itself, which determined the high relapse of earlier studies. The aim of this study was to investigate rates of cardioversion. maintenance of sinus rhythm and predictors of subsequent relapse in a homogeneous group of patients without evidence of any co-existent cardiac disease. Methods and Results We report on a retrospective series of 106 patients with thyrotoxicosis-induced fibrillation but no other heart disease: 87% had been in atrial fibrillation for >12 months (median duration 28.5, interquartile range 15-47 months). Cardioversion was attempted using disopyramide and then electric shock. Ninety-eight patients were successfully cardioverted: at late follow-up, 80.6 +/- 37 months (mean +/- SD), 67% were in sinus rhythm. Conclusion Although a relationship between the duration of fibrillation and maintenance of sinus rhythm was found, the high proportion remaining in sinus rhythm, compared with other series, suggests this influence may be less important than the presence or absence of structural heart disease. (C) 2000 The European Society of Cardiology.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 33 条
[1]  
ABERG H, 1968, ACTA MED SCAND, V184, P433
[2]  
ALLESSIE MA, 1986, CARDIAC ELECTROPHYSI, P265
[3]   CHOICE OF THERAPY FOR GRAVES HYPERTHYROIDISM [J].
BECKER, DV .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (07) :464-466
[4]   NONRHEUMATIC ATRIAL-FIBRILLATION - RISK OF STROKE AND ROLE OF ANTITHROMBOTIC THERAPY [J].
CAIRNS, JA ;
CONNOLLY, SJ .
CIRCULATION, 1991, 84 (02) :469-481
[5]  
*CARD ARTH SUPPR T, 1989, NEW ENGL J MED, V321, P1406
[6]   HYPERTHYRODISM AND MITRAL-VALVE PROLAPSE [J].
CHANNICK, BJ ;
ADLIN, EV ;
MARKS, AD ;
DENENBERG, BS ;
MCDONOUGH, MT ;
CHAKKO, CS ;
SPANN, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (09) :497-500
[7]   EFFICACY AND SAFETY OF QUINIDINE THERAPY FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION - A METAANALYSIS OF RANDOMIZED CONTROL TRIALS [J].
COPLEN, SE ;
ANTMAN, EM ;
BERLIN, JA ;
HEWITT, P ;
CHALMERS, TC .
CIRCULATION, 1990, 82 (04) :1106-1116
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]   ECHOCARDIOGRAPHIC AND CLINICAL PREDICTORS FOR OUTCOME OF ELECTIVE CARDIOVERSION OF ATRIAL-FIBRILLATION [J].
DITTRICH, HC ;
ERICKSON, JS ;
SCHNEIDERMAN, T ;
BLACKY, AR ;
SAVIDES, T ;
NICOD, PH .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (03) :193-197
[10]  
GAJEWSKI J, 1981, Journal of the American Medical Association, V245, P1540, DOI 10.1001/jama.245.15.1540